SCYNEXIS Stock

SCYNEXIS Current Ratio

The Current Ratio of SCYNEXIS (SCYX) as of Sep 4, 2026 is 2.96. In the previous year, Current Ratio was 6.26 — a change of -52.68% (lower).

Current Ratio

2.96

YoY

-52.68%

Last updated:

Current Ratio of SCYNEXIS is 2026 2.96 . Current Ratio of SCYNEXIS was 2025 6.26 . It decreases by -52.68% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Current Ratio of SCYNEXIS is 2.96 in 2026.

Current Ratio of SCYNEXIS changed from 6.26 to 2.96, representing a -52.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — SCYNEXIS

All Key Metrics — SCYNEXIS